exelixis.org

Exelixis

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. Our first commercial product, COMETRIQ. Exelixis In The News. Jul 28, 2015. Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015.

http://www.exelixis.org/

OVERVIEW OF exelixis.org

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR EXELIXIS.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.8 out of 5 with 8 reviews

5 star

2

4 star

2

3 star

4

2 star

0

1 star

0

Hey there! Start your review of exelixis.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT EXELIXIS.ORG

Exelixis, Inc.

Exelixis, Inc.

12808 Gra●●●●●●●●●kway West

Jack●●●●ille , FL, 32258

US

1.57●●●●8780

nv●●●●●●●●●@networksolutionsprivateregistration.com

View this contact

Exelixis, Inc.

Exelixis, Inc.

12808 Gra●●●●●●●●●kway West

Jack●●●●ille , FL, 32258

US

1.57●●●●8780

nv●●●●●●●●●@networksolutionsprivateregistration.com

View this contact

Network Solutions, LLC.

Network Solutions, LLC.

13200 Wo●●●●●●●●rk Drive

He●●on , VA, 20171-3025

US

1.88●●●●9675

1.57●●●●4620

cu●●●●●●●●●●●●●@networksolutions.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: n/a
UPDATED: 2010 August 09
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

NAME SERVERS

1: ns87.worldnic.com
2: ns88.worldnic.com

REGISTRAR

Network Solutions, LLC (R63-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

0

SITE IP

0.0.0.0

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Exelixis | exelixis.org Reviews

<META> DESCRIPTION

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. Our first commercial product, COMETRIQ. Exelixis In The News. Jul 28, 2015. Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015.

<META> KEYWORDS

1 learn more

2 welcome

3 more news

4 view press release

5 listen to webcast

6 boxed warning

7 stock

8 nasdaq

9 exel

10 price

CONTENT

Page content here

KEYWORDS ON PAGE

learn more,welcome,more news,view press release,listen to webcast,boxed warning,stock,nasdaq,exel,price,volume,20 minute delay,about us,management,board of directors,collaborations,locations,cometriq,pipeline,cobimetinib,partnered compounds,annual reports

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Exelixis | exelixis.org Reviews

https://exelixis.org

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. Our first commercial product, COMETRIQ. Exelixis In The News. Jul 28, 2015. Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015.

INTERNAL PAGES

exelixis.org

1

Clinical Trials | Exelixis

http://www.exelixis.org/clinical-trials

Exelixis is conducting a broad global clinical development program for cabozantinib in a wide variety of cancer settings. The program includes multiple Exelixis-sponsored global, randomized phase 3 pivotal trials, as well as earlier stage studies conducted through our Investigator-Sponsored Trial program and our collaboration with the National Cancer Institute’s Cancer Therapy Evaluation Program. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. FAQs about Clinical Trials.

2

Analyst Coverage | Exelixis

http://www.exelixis.org/investors-media/analyst-coverage

National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.

3

Pipeline | Exelixis

http://www.exelixis.org/pipeline

The Exelixis pipeline includes our lead compounds, cabozantinib and cobimetinib, as well as other programs that are the subject of partnerships and collaborations with other biopharmaceutical companies. An additional wholly-owned compound, XL888, is the subject of ongoing clinical research through our Investigator-Sponsored Trial. Program. Safety and efficacy for these compounds in the unapproved uses or indications described below have not yet been established. XL888 is a highly potent, orally bioavaila...

4

Corporate Governance | Exelixis

http://www.exelixis.org/investors-media/governance

National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.

5

Investigator Sponsored Trials | Exelixis

http://www.exelixis.org/clinical-trials/investigator_sponsored_trials

Cabozantinib is also being evaluated in a variety of investigator sponsored trials (ISTs). You can access a detailed list of cabozantinib clinical studies, including ISTs, at www.ClinicalTrials.gov. For further information regarding all clinical trials, please contact Exelixis Medical Information at 1-888-EXELIXIS (1-888-393-5494) or at druginfo@exelixis.com. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

OTHER SITES

exelixis.edu.gr

ΕΞΕΛΙΞΙΣ ΚΑΡΔΙΤΣΑ - ΚΕΚ - EXELIXIS - Κέντρο Κατάρτισης & Τεχνολογικής Καινοτομίας

Alpha;ΡΘΡΟΓΡΑΦΙΑ. Upsilon;ΠΟΣΤΗΡΙΞΗ ΚΑΙΝΟΤΟΜΩΝ ΙΔΕΩΝ. Gamma;ΡΑΦΕΙΟ ΑΠΑΣΧΟΛΗΣΗΣ and ΚΑΤΑΡΤΙΣΗΣ. Epsilon;ΠΕΝΔΥΤΙΚΑ and ΧΡΗΜΑΤΟΔΟΤΙΚΑ ΝΕΑ. Epsilon;ΠΙΚΟΙΝΩΝΙΑ. ΛΑΕΚ Επιχειρήσεων and Συλλόγων. Γραφτείτε στο Newsletter και ενημερωθείτε για προγράμματα ανέργων και επιχειρήσεων. Νέο Πρόγραμμα Επιταγής Κατάρτισης (Voucher) για ανέργους έως 29 ετών στον κλάδο του Τουρισμού. Το πρόγραμμα επιταγής κατάρτισης (Voucher) ίσως είναι η ευκαιρία σου! Τηλεφώνησε στο 2441040050 για περισσότερες πληροφορίες. 3 προγράμματα γι...

exelixis.gr

exelixis.gr -&nbspThis website is for sale! -&nbspexelixis Resources and Information.

exelixis.info

Exelixis AE

Email επικοινωνίας: info@exelixis.info. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ 2016. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ 2014. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΑΠΟΤΕΛ 2014. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΕΚΜ 2014. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ 2013. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΑΠΟΤΕΛ 2013. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΕΚΜ 2013. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ 2012. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΑΠΟΤΕΛ 2012. ΒΑΡΕΛΑ ΑΦΟΙ Α Ε ΙΣΟΛΟΓΙΣΜΟΣ ΕΚΜ 2012.

exelixis.net

Exelixis

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. Our first commercial product, COMETRIQ. Exelixis In The News. Jul 28, 2015. Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015.

exelixis.net.gr

Αρχική

Sigma;ας Καλωσορίζουμε στην ιστοσελίδα της εταιρίας Συμβούλων Ανάπτυξης Εξέλιξις! Σύμβουλοι Ανάπτυξης Επιχειρήσεων είναι μια σύγχρονη και δυναμικά αναπτυσσόμενη εταιρεία παροχής ολοκληρωμένων υπηρεσιών και συμβουλών σε θέματα επιδοτήσεων, ποιότητας, ασφάλειας τροφίμων και περιβαλλοντικών μελετών. Έχει έδρα τη Ρόδο και δραστηριοποιείται, κύρια, στις Περιφέρειες Νοτίου και Βορείου Αγαίου. Ιδρύθηκε το 2001. Info (@) exelixis.net.gr. 28ης Οκτωβρίου 27, Ρόδος, 85100. Lorem ipsum dolor sit amet, consectetur ad...

exelixis.org

Exelixis

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. Our first commercial product, COMETRIQ. Exelixis In The News. Jul 28, 2015. Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015.

exelixis.ro

Home Page

P1 Gloves GRIP Black Nr.9. SH-08/FL 1m straight silicone 0.8mm. NOMEX TOP UNDERWEAR WHITE SIZE 4. STANDARD FIT TOP UNDERWEAR 100% NOMEX SIZE4. GP-VO301-CB TC2000 CARBON STEERIG WHEEL. HC50-70 Hose Clamp 60mm. C-63 Slicone coupler 63mm. November 10, 2017. Volkswagen Golf 6 R. November 09, 2017. November 08, 2017. Volkswagen Golf 4 R32. Subscribe to the newsletter! Stay up to date with the latest news and products. Sign Up for Our Newsletter:. Erou Nita Pintea Street, no.4, Voluntari, Ilfov, Romania.

exelixis4u.gr

Καλωσήρθατε στην exelixis - Εκπαίδευση μέσω διαδικτύου - exelixis4u.gr

Αρχείο - (Η ιστορία μας). Νέα προσφορά ECDL 6-10-2012. Είμαστε geitones; Έχετε Έκπτωση. Η exelixis της τεχνολογίας. Έλλειψη ταλέντων - έρευνα Manpower. Τα οφέλη της πιστοποίησης. Πιστοποιηθείτε σε Windows 7 και Office 2010. Αντιστοίχιση εντολών Office 2003 και Office 2007. Δημιουργία ιστοσελίδας με Joomla. Προετοιμασία για την αγορά εργασίας. Office Procedures Level 1. Office Procedures Level 2. Οργανισμός City and Guilds. Εκπαιδευτικό λογισμικό προετοιμασίας για το ECDL. Αρχάριος ή έμπειρος;. Έτσι ο αρχ...

exelixisapps.com

Exelixis | pharmaceutical industry news

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients. Exelixis In The News. May 14, 2014.

exelixisetuners.com

Exelixisetuners

FB VISIT' translate }. SENT US MESSAGE' translate}. NAME' translate } *. NAME ERROR MESSAGE' translate }. EMAIL' translate } *. EMAIL INVALID ERROR MESSAGE' translate }. YOUR REQUEST' translate } *. MSG ERROR MESSAGE' translate }. SENT SUBMIT' translate }.

exelixisgames.gr

Exelixis Games

0 προϊόν(ντα) - 0,00. Το καλάθι σας είναι άδειο! Βάλτε στόχο την διασκέδαση! Δώστε ώθηση στην επιχείρηση σας! Εκμεταλλευτείτε τον εξοπλισμό σας! Κέρδος διασκεδάζοντας τους πελάτες σας! Κάντε το κατάστημα σας αποδοτικότερο! Kερματοδέκτης - Κουτί χρονοχρέωσης. Kερματοδέκτης - Κουτί χρονοχρέωσης. Κουτί χρονοχρέωσης με ηλεκτρονικό κερματοδέκτη με δυνατότητα χρέωσης με την ώρα. Κατάλληλα σχεδιασμένο για internet cafe αλλά και σε οποιαδήποτε επιχείρηση. Είναι προγραμματισμένο να δέχεται 0,5 - 1 -2. Δυνατότητα ...